Orexo AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Nikolaj Arrild Sørensen, was filed 04 Sept 2025.
Orexo AB: what insiders have been doing
Orexo AB is a Health Care company. Its directors and officers file their transactions with Finansinspektionen. Nothing new has been filed by managers of Orexo AB in twelve months, the latest record being from 4 September 2025.
Our records for Orexo AB go back to 2016, with 79 purchases and 4 sales on the open market in total.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Who traded when
BuySale+1 other insider
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,393 shares0AktieISIN SE0000736415FI:csv-a152137bc1ca61c6bd05
- 6 shares0AktieISIN SE0000736415FI:A003S047-1Canonical exit: 1 Dec 2025 (T+90)
- 149 shares0AktieISIN US68616W1027FI:csv-28f13463161b7158b117
- 1 shares0AktieISIN US68616W1027FI:A003S008-1Canonical exit: 1 Dec 2025 (T+90)
- 2 shares0AktieISIN SE0000736415FI:csv-5049bb85263072a0b50eCanonical exit: 27 Nov 2025 (T+90)
- 452 shares0AktieISIN SE0000736415FI:csv-64278bd4a6b508f1680f
- 15,300 shares@ SEK 20.75690.2% of flowAktieISIN SE0000736415FI:csv-8bfc666cfc3bcdbdd92dCanonical exit: 9 Sept 2025 (T+90)
- 1,700 shares@ SEK 20.20699.8% of flowAktieISIN SE0000736415FI:csv-b50c6934a0697c82a637Canonical exit: 9 Sept 2025 (T+90)
- 3,534 shares@ SEK 15.280.0053% mcap100.0% of flowAktieISIN SE0000736415FI:A003P189-1Canonical exit: 31 Aug 2025 (T+90)
- 13,433 shares0AktieISIN US68616W1027FI:csv-95dd5a1e646b12da5b7a
- 3,493 shares0AktieISIN US68616W1027FI:A003P105-1
- 3,314 shares@ SEK 15.375925.1% of flowAktieISIN SE0000736415FI:csv-7662a4f3737378758f3bCanonical exit: 21 Aug 2025 (T+90)
- 13,433 shares0AktieISIN SE0000736415FI:csv-95648d4ed6ea74434103
- 2,000 shares@ SEK 13.6811.3% of flowAktieISIN SE0000736415FI:csv-5d8f5f1da8e3263fa921Canonical exit: 3 Jul 2025 (T+90)
- 9,608 shares0AktieISIN SE0000736415FI:csv-eec16d7b13ee39cf3911
- 295 shares0AktieISIN SE0000736415FI:csv-7da8b4bb2130c37f2ee6
- 30,108 shares@ SEK 14.870.044% mcap92.8% of flowAktieISIN SE0000736415FI:A003O679-1Canonical exit: 17 Aug 2025 (T+90)
- 2,460 shares@ SEK 14.300.0034% mcap7.2% of flowAktieISIN SE0000736415FI:A003N442-1Canonical exit: 10 Jul 2025 (T+90)
- 3,500 shares@ SEK 13.580.9% of flowAktieISIN SE0000736415FI:csv-c03d3347ac002f21acf8Canonical exit: 3 Jul 2025 (T+90)
- 8,189 shares@ US$1.568.1% of flowAktieISIN US68616W1027FI:csv-70db208c7a2b717f05d2
- 174 shares0AktieISIN SE0000736415FI:csv-f917f019389326ef26f4
- 3,800 shares@ US$2.3526.8% of flowAktieISIN US68616W1027FI:csv-77fdf4cf3cb434912439Canonical exit: 12 Sept 2024 (T+90)
- 3,562 shares0AktieISIN SE0000736415FI:csv-e42393158dc9d5da677c
- 13,133 shares0AktieISIN SE0000736415FI:csv-26745249bebdf339741b
- 2,332 shares@ SEK 21.2831.4% of flowAktieISIN SE0000736415FI:csv-ba84598ff6e8ba7fbcd9Canonical exit: 5 Sept 2024 (T+90)
25 of 99 declarations
About Orexo AB
Orexo AB is a Swedish pharmaceutical company focused on developing treatments for addiction and pain disorders. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
